2 Biotech Takeover Targets Under $7
Here are two interesting biopharma stocks that currently go for under $7 a share that are very undervalued on a standalone basis. They also make logical buyout targets should M&A activity indeed pick up here in the second quarter now that biotech appears it is back in rally mode.
Trump Biotech Special: A $7 Stock with “Yuge” Potential
Like the Donald’s current wife, this stock comes from outside the United States and is based in Canada. It has multiple “shots on goal”, plenty of cash on the balance sheet, and a recent analyst upgrade. As Mr. Trump would say, it has “Yuge” potential.
Buy and Hold This Dividend Stock Forever
The company has paid a dividend EVERY month since September 2008, has increased its monthly dividend twice every year since 2011, and has paid a bonus dividend twice a year since 2012, boosting the yield over 7%.
There is simply no other stock that can be counted on to pay you 14 dividends per year AND provide a growing cash income stream.
7 Stocks to Sell Now
FREE report reveals the names of 7 big-name stocks insiders are dumping. If you own any of these 7 stocks, sell them immediately! Get the full list of dangerous stocks to sell now – yours FREE.